Create readme.md

data/2024/2024-09-11/readme.md

@@ -0,0 +1,36 @@
+Personalized dosing
+===================
+
+## Background
+
+Why personalized dosing?
+
+„Again and again, it has been shown that certain patients benefit more from individual drugs, 
+while others suffer more heavily from side effects…
+…and still they are usually treated with a standard dose."
+Free translation of a quote from Prof. Dr. Dr. Gerd Geisslinger, Executive Director, 
+Fraunhofer Institute for Translational Medicine and Pharmacology, Frankfurt
+
+## Data set
+
+A simulated dose response [data set](WWW54ExampleData.csv) 
+
+* dose: 	dose levels (0, 100, 200 mg)
+* target:	continuous response variable (higher is better)
+* subgroup variables:
+   + bmi (body mass index: ‘low BMI’ or ‘high BMI’)	
+   + age (‘<40 years’ or ‘≥40 years’)
+   + race (‘Black’, ‘Asian’, ‘White’)
+   + sex (‘Female’, ‘Male’)
+   + type (type of disease: ‘Acute disease’ or ‘Chronic disease’)
+
+
+## The Challenge
+
+Aim of the visualisation
+
+* Identify subgroups with a dose response that deviates from the remaining study participants 
+* Therewith potential subgroups for personalized dosing could be identified 
+
+
+